Skip to main content


Corporate America Is Sitting on $5 Trillion of M&A Firepower

Wow. Corporate America is sitting on massive amounts of cash that could be unleashed on deals, according to new research from Citi.

Stock Market Drop Not Seen Dampening Healthcare Deal Activity

A steeper fall might cause both buyers and sellers to re-think potential deals, but so far that doesn't seem to be the case yet.

Biotech, pharma stocks tumble amid big market sell-off

Vertex Pharmaceuticals, Amgen and Johnson and Johnson were among the big movers in the biotech and pharmaceutical sectors.

Why 2018 will be better for biotech deals than 2017

Analysts see a year of robust deal action ahead due in part to clarity from a tax standpoint.

Celgene says Juno, Impact deals won't be its last

The biopharmaceutical giant's top executive says the company will continue to aggressively invest in R&D and deploy capital to acquire or license assets.

Breaking News

Fed Inflation Gauge Eases Again In May, But Inflation Pressures Clip Consumer Spending

While overall inflation pressures are easing modestly, the impact of the fastest inflation in four decades is taking its toll on spending, BEA data indicated Thursday.

Pfizer Stock Jumps On $3.2 Billion U.S. Covid Vaccine Sale, FDA Paxlovid Approval Filing

“As the Covid pandemic continues to evolve and be highly unpredictable, we must remain vigilant in protecting those who are at greatest risk of getting very sick from Covid," said CEO Albert Bourla.

Walgreens Stock Slides After Q3 Profit Beat, $683 Million Florida Opioid Charge

"WBA delivered strong execution across operating segments and against very robust growth last year," said CEO Rosalind Brewer.

Micron Earnings Preview: Will Critical Support Hold?

Micron is set to report earnings on Thursday after the close, but the stock sits on critical support. Will it hold or will it fold?